Omada Health (OMDA) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $15.30 (+4.94%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Apr 8, 2026 | Elizabeth Anderson | Evercore ISI | $15.00 | -2.0% |
| Jan 16, 2026 | David Roman | Goldman Sachs | $26.00 | +69.9% |
| Jan 5, 2026 | Saket Kalia | Barclays | $22.00 | +43.8% |
| Oct 8, 2025 | Elizabeth Anderson | Evercore ISI | $27.00 | +76.5% |
Top Analysts Covering OMDA
OMDA vs Sector & Market
| Metric | OMDA | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.41 |
| Analyst Count | 13 | 8 | 18 |
| Target Upside | +46.4% | +1150.2% | +14.9% |
| P/E Ratio | -66.71 | 6.93 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $317M | $319M | $321M | 8 |
| 2027-03-31 | $88M | $88M | $90M | 3 |
| 2027-06-30 | $91M | $92M | $93M | 3 |
| 2027-09-30 | $96M | $97M | $98M | 3 |
| 2027-12-31 | $101M | $102M | $103M | 3 |
| 2028-03-31 | $102M | $102M | $104M | 2 |
| 2028-06-30 | $105M | $106M | $108M | 2 |
| 2028-09-30 | $110M | $111M | $113M | 2 |
| 2028-12-31 | $115M | $116M | $118M | 2 |
| 2029-12-31 | $498M | $505M | $513M | 3 |
| 2030-12-31 | $569M | $577M | $586M | 6 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-0.10 | $-0.10 | $-0.10 | 4 |
| 2027-03-31 | $-0.12 | $-0.12 | $-0.12 | 1 |
| 2027-06-30 | $-0.01 | $-0.01 | $-0.01 | 1 |
| 2027-09-30 | $0.09 | $0.09 | $0.09 | 1 |
| 2027-12-31 | $0.08 | $0.08 | $0.08 | 1 |
| 2028-03-31 | $0.00 | $0.00 | $0.00 | 1 |
| 2028-06-30 | $0.00 | $0.00 | $0.00 | 1 |
| 2028-09-30 | $0.00 | $0.00 | $0.00 | 1 |
| 2028-12-31 | $0.00 | $0.00 | $0.00 | 1 |
| 2029-12-31 | $0.00 | $0.00 | $0.00 | 1 |
| 2030-12-31 | $0.00 | $0.00 | $0.00 | 0 |
Frequently Asked Questions
What is the analyst consensus for OMDA?
The consensus among 13 analysts covering Omada Health (OMDA) is Buy with an average price target of $24.80.
What is the highest price target for OMDA?
The highest price target for OMDA is $27.00, set by Elizabeth Anderson at Evercore ISI on 2025-10-08.
What is the lowest price target for OMDA?
The lowest price target for OMDA is $15.00, set by Elizabeth Anderson at Evercore ISI on 2026-04-08.
How many analysts cover OMDA?
13 analysts have issued ratings for Omada Health in the past 12 months.
Is OMDA a buy or sell right now?
Based on 13 analyst ratings, OMDA has a consensus rating of Buy (2.00/5) with a +46.4% upside to the consensus target of $24.80.
What are the earnings estimates for OMDA?
Analysts estimate OMDA will report EPS of $-0.10 for the period ending 2026-12-31, with revenue estimated at $319M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.